Lagipeg Injection 5 ml

Lagipeg Injection 5 ml is used in the treatment of Acute Lymphoblastic Leukaemia (ALL) and hypersensitivity to asparaginase. Acute lymphoblastic leukaemia is a type of cancer where the body makes too many abnormal white blood cells. These cells proliferate quickly and interfere with normal blood cell production, causing symptoms such as fatigue and easy bruising. It is more common in children but can also affect adults.

Lagipeg Injection 5 ml contains Pegylated L-asparaginase. It works by reducing asparagine, which is necessary for leukaemia cells to survive. L-asparaginase breaks down asparagine in the blood. Since leukaemia cells cannot produce it on their own, they rely on an external source. With the reduction of asparagine, the leukaemia cells are unable to proliferate and eventually die.

A healthcare professional will administer Lagipeg Injection 5 ml. In some cases, this medicine may cause side effects like nausea, vomiting, diarrhoea, fever, tiredness, and dizziness. The majority of these side effects may not require medical treatment and will subside with time. However, if the side effects persist or worsen, see a doctor.

Before starting treatment, be sure to inform your doctor about any other medications or herbal products you are currently taking. Lagipeg Injection 5 ml is contraindicated for patients with a history of severe allergic reactions, pancreatitis, blood clots, or serious bleeding caused by prior L-asparaginase treatment. Pregnant and breastfeeding women should consult their doctor before receiving Lagipeg Injection 5 ml. This medicine is given to children in doses as advised by the doctor, depending on the age. Lagipeg Injection 5 ml should be stored in cold places at 2°C to 8°C.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Lagipeg Injection 5 ml will be administered by a healthcare professional in a medical setting.
• Do not self-administer.

Lagipeg Injection 5 ml is a pegylated form of L-asparaginase, an enzyme that breaks down L-asparagine. This enzyme specifically targets leukaemia cells in acute lymphoblastic leukaemia (ALL), which cannot produce enough L-asparagine on their own and depend on it from the blood for protein production. It works by breaking down the amino acid asparagine, which leukaemia cells need to proliferate. Its pegylated form reduces the risk of hypersensitivity reactions and provides a longer duration of action, allowing for less frequent dosing. This makes it more tolerable for patients, especially those who have experienced allergic reactions to other forms of asparaginase.

Inform your doctor if you have had severe allergic reactions to asparaginase, bleeding problems, or blood clots. Let your doctor know if you get a fever, have liver issues, or take medicines that could harm your liver. Lagipeg Injection 5 ml can cause liver damage, brain problems, or pancreas issues. If you experience stomach pain, let your doctor know. Lagipeg Injection 5 ml is contraindicated for patients with a history of severe allergic reactions, pancreatitis, blood clots, or serious bleeding caused by prior L-asparaginase treatment. If you are pregnant, planning for pregnancy, or are breastfeeding, please inform your doctor before receiving Lagipeg Injection 5 ml. Avoid driving after receiving Lagipeg Injection 5 ml if you experience drowsiness or dizziness.